Does TILDRAKIZUMAB-ASMN Cause Product administration error? 24 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Product administration error have been filed in association with TILDRAKIZUMAB-ASMN. This represents 1.5% of all adverse event reports for TILDRAKIZUMAB-ASMN.
24
Reports of Product administration error with TILDRAKIZUMAB-ASMN
1.5%
of all TILDRAKIZUMAB-ASMN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product administration error From TILDRAKIZUMAB-ASMN?
Of the 24 reports, 1 (4.2%) required hospitalization.
Is Product administration error Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TILDRAKIZUMAB-ASMN. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does TILDRAKIZUMAB-ASMN Cause?
Product dose omission issue (363)
Drug ineffective (223)
Psoriasis (86)
Death (84)
Product storage error (74)
Self-medication (74)
Off label use (66)
Condition aggravated (63)
Rash (54)
Pruritus (52)
What Other Drugs Cause Product administration error?
HYDROXYPROGESTERONE CAPROATE (972)
ACETAMINOPHEN (666)
CENEGERMIN-BKBJ (613)
LEUPROLIDE (595)
EVOLOCUMAB (565)
ADALIMUMAB (543)
METHYLPHENIDATE (414)
OLMESARTAN MEDOXOMIL (314)
ASPIRIN (241)
SECUKINUMAB (225)
Which TILDRAKIZUMAB-ASMN Alternatives Have Lower Product administration error Risk?
TILDRAKIZUMAB-ASMN vs TILIDINE
TILDRAKIZUMAB-ASMN vs TIMOLOL
TILDRAKIZUMAB-ASMN vs TIMOLOL\TRAVOPROST
TILDRAKIZUMAB-ASMN vs TINIDAZOLE
TILDRAKIZUMAB-ASMN vs TINZAPARIN